IDXX · IDEXX Laboratories, Inc.

Summary

IDEXX Laboratories, Inc. announced that Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, will cease her role effective April 13, 2026, and provide advisory services until July 13, 2026, under a Separation Agreement providing $2,286,000 in total separation benefits due to position elimination.

Key takeaways

• Nimrata Hunt, PhD, to cease role as Executive Vice President, Global Strategy and Commercial on April 13, 2026
• Advisory services as Special Advisor until Final Employment Date of July 13, 2026
• Separation benefits total $2,286,000 including $1,230,000 salary continuation for 104 weeks and $984,000 target bonus
• Additional benefits: $50,000 COBRA premiums for 78 weeks, $10,000 transition assistance, $12,000 max tax/financial planning
• Position eliminated, deemed termination without cause
• Unvested stock awards forfeit as of July 13, 2026; vested options remain exercisable per agreements